Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Akhil Rajendra, Vanita Noronha, Amit Joshi, Vijay Maruti Patil, Nandini Menon & Kumar Prabhash. (2020) Palliative chemotherapy in head and neck cancer: balancing between beneficial and adverse effects. Expert Review of Anticancer Therapy 20:1, pages 17-29.
Read now
Read now
Articles from other publishers (30)
Zimeng Wang, Hongzhou Shang, Linghuan Gao & Ning Qiao. (2023) Research Progress of Plant Active Ingredients in Pharmaceutical Cocrystal. Current Drug Delivery 20:10, pages 1405-1424.
Crossref
Crossref
Fruzsina Kiss, Krisztina Pohóczky, Anikó Görbe, Fanni Dembrovszky, Szabolcs Kiss, Péter Hegyi, Lajos Szakó, Lilla Tóth, Éva Somogyiné Ezer, Eszter Szalai & Zsuzsanna Helyes. (2022) Addition of epidermal growth factor receptor inhibitors to standard chemotherapy increases survival of advanced head and neck squamous cell carcinoma patients: A systematic review and meta‐analysis. Oral Diseases 29:5, pages 1905-1919.
Crossref
Crossref
Chandan Gupta, Isha Naik, Mala Menon, Premlata Ambre & Evans Coutinho. (2023) A Review on Exploring the Opportunities of Polymer Drug Conjugated
Systems for Targeted Cancer Treatment. Current Drug Delivery 20:1, pages 8-30.
Crossref
Crossref
Yan He, Junsong Zeng, Zhigong Wei, Yan Huang, Lianlian Yang, Xiaolin Hu, Yonglin Su & Xingchen Peng. (2022) Comparison of Second-Line Treatments for Patients with Platinum-Resistant Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Systematic Review and Bayesian Network Meta-Analysis. Cancers 14:18, pages 4472.
Crossref
Crossref
Jingjing Sha, Yunpeng Bai, Huy Xuan Ngo, Tatsuo Okui & Takahiro Kanno. (2021) Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition. Biomolecules 11:6, pages 893.
Crossref
Crossref
Razia Irshad, Ghulam Haider, Madiha Hashmi & Anusha Hassan. (2021) Efficacy of Gefitinib and Methorexate in Patients With Advanced Stage and Recurrent Head and Neck Cancer. Cureus.
Crossref
Crossref
Lingrong Tang, Tingting Liu, Jun Chen, Jun Dang & Guang Li. (2021) Immune-checkpoint inhibitors versus other systemic therapies in advanced head and neck cancer: a network meta-analysis. Immunotherapy 13:6, pages 541-555.
Crossref
Crossref
Wen-Ting Lv, Xiao-Xu Liu, Xia-Lin Dai, Xiang-Tian Long & Jia-Mei Chen. (2020) A 5-fluorouracil–kaempferol drug–drug cocrystal: a ternary phase diagram, characterization and property evaluation. CrystEngComm 22:46, pages 8127-8135.
Crossref
Crossref
Ashley Lau, Wei-fa Yang, Kar-Yan Li & Yu-xiong Su. (2020) Systemic Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma- A Systematic Review and Meta-Analysis. Critical Reviews in Oncology/Hematology 153, pages 102984.
Crossref
Crossref
Byoung Chul Cho, Amaury Daste, Alain Ravaud, Sébastien Salas, Nicolas Isambert, Edward McClay, Ahmad Awada, Christian Borel, Laureen S Ojalvo, Christoph Helwig, P Alexander Rolfe, James L Gulley & Nicolas Penel. (2020) Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort. Journal for ImmunoTherapy of Cancer 8:2, pages e000664.
Crossref
Crossref
Przemysław Koźmiński, Paweł Krzysztof Halik, Raphael Chesori & Ewa Gniazdowska. (2020) Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers. International Journal of Molecular Sciences 21:10, pages 3483.
Crossref
Crossref
Janneke C. Ham, Esther Meerten, W. Edward Fiets, Laurens V. Beerepoot, Frank J. F. Jeurissen, Marije Slingerland, Marianne A. Jonker, Olga Husson, Winette T. A. Graaf & Carla M. L. Herpen. (2020) Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib‐randomized phase II study Commence. Head & Neck 42:5, pages 828-838.
Crossref
Crossref
Joël Guigay, Esma Sâada-Bouzid, Frédéric Peyrade & Cécile Michel. (2019) Approach to the Patient with Recurrent/Metastatic Disease. Current Treatment Options in Oncology 20:8.
Crossref
Crossref
Leonardo Muratori, Anna La Salvia, Paola Sperone & Massimo Di Maio. (2019) Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review. Critical Reviews in Oncology/Hematology 139, pages 41-52.
Crossref
Crossref
Xiaoxia Tang, Juan He, Bo Li, Yi Zheng, Kejia Li, Shun Zou & Long Chen. (2019) Efficacy and Safety of Gefitinib in Patients with Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials. Journal of Oncology 2019, pages 1-9.
Crossref
Crossref
Esma Saada-Bouzid, Frederic Peyrade & Joël Guigay. (2019) Molecular genetics of head and neck squamous cell carcinoma. Current Opinion in Oncology 31:3, pages 131-137.
Crossref
Crossref
Zhipeng Li, Jipei Liao, Zejia Yang, Eun Yong Choi, Rena G. Lapidus, Xuefeng Liu, Kevin J. Cullen & Hancai Dan. (2018) Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer. British Journal of Cancer 120:3, pages 306-316.
Crossref
Crossref
Lillian L. Siu, Caroline Even, Ricard Mesía, Eva Remenar, Amaury Daste, Jean-Pierre Delord, Jürgen Krauss, Nabil F. Saba, Lisle Nabell, Neal E. Ready, Irene Braña, Nuria Kotecki, Dan P. Zandberg, Jill Gilbert, Hisham Mehanna, Marcelo Bonomi, Anthony Jarkowski, Giovanni Melillo, Jon M. Armstrong, Sophie Wildsmith & Jérôme Fayette. (2019) Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC. JAMA Oncology 5:2, pages 195.
Crossref
Crossref
Dan P. Zandberg, Alain P. Algazi, Antonio Jimeno, James S. Good, Jérôme Fayette, Nathaniel Bouganim, Neal E. Ready, Paul M. Clement, Caroline Even, Raymond W. Jang, Stuart Wong, Ulrich Keilholz, Jill Gilbert, Moon Fenton, Irene Braña, Stephanie Henry, Eva Remenar, Zsuzsanna Papai, Lillian L. Siu, Anthony Jarkowski, Jon M. Armstrong, Kobby Asubonteng, Jean Fan, Giovanni Melillo & Ricard Mesía. (2019) Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. European Journal of Cancer 107, pages 142-152.
Crossref
Crossref
Christian Borel, Olivier Regnier-Gavier, Hélène Carinato, Sébastien Guihard, Delphine Antoni, Martin Demarchi, Florian Sirlin, Delphine Exinger, Emilie Petit-Jean, Alicia Thiery, Guy Bronner, Philippe Schultz, Henri Flesch, Véronique Frasie, Danielle Prébay, Thierry Petit, Alain C. Jung, Mickael Burgy & Pierre Coliat. (2018) Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer. Oncotarget 9:101, pages 37581-37588.
Crossref
Crossref
Yong Xin, Qiuyue Yan, ChunSheng Yang, Fan Jiang, Wenwen Guo, Qian Huang, Guan Jiang & Longzhen Zhang. (2018) Meta-analysis of the effects of anti-epidermal growth factor receptor on recurrent/metastatic head and neck squamous cell carcinoma. Medicine 97:51, pages e13717.
Crossref
Crossref
Hunter John Piegols, Marilia Takada, Maciej Parys, Thomas Dexheimer & Vilma Yuzbasiyan-Gurkan. (2018) Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma. Oncotarget 9:69, pages 33098-33109.
Crossref
Crossref
Maxine D. Fisher, Ancilla W. Fernandes, Temitope O. Olufade, Paul J. Miller, Mark S. Walker & Moon Fenton. (2018) Effectiveness Outcomes in Patients With Recurrent or Refractory Head and Neck Cancers: Retrospective Analysis of Data From a Community Oncology Database. Clinical Therapeutics 40:9, pages 1522-1537.
Crossref
Crossref
H. Boyes, J. Barraclough, R. Ratansi, S.N. Rogers & A. Kanatas. (2018) Structured review of the patient-reported outcome instruments used in clinical trials in head and neck surgery. British Journal of Oral and Maxillofacial Surgery 56:3, pages 161-167.
Crossref
Crossref
Khaled A. Tolba. 2018. Oral, Head and Neck Oncology and Reconstructive Surgery. Oral, Head and Neck Oncology and Reconstructive Surgery
291
313
.
Matthew C. Ward, Chirag Shah, David J. Adelstein, Jessica L. Geiger, Jacob A. Miller, Shlomo A. Koyfman & Mendel E. Singer. (2017) Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer☆. Oral Oncology 74, pages 49-55.
Crossref
Crossref
Athanassios Argiris, Kevin J. Harrington, Makoto Tahara, Jeltje Schulten, Pauline Chomette, Ana Ferreira Castro & Lisa Licitra. (2017) Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck. Frontiers in Oncology 7.
Crossref
Crossref
Minhui Zhu, Shicai Chen, Libo Hua, Caiyun Zhang, Mengjie Chen, Donghui Chen, Yinmei Dong, Yingying Zhang, Meng Li, Xianmin Song, Huaiwen Chen & Hongliang Zheng. (2017) Self-targeted salinomycin-loaded DSPE-PEG-methotrexate nanomicelles for targeting both head and neck squamous cell carcinoma cancer cells and cancer stem cells. Nanomedicine 12:4, pages 295-315.
Crossref
Crossref
Seema Gupta, Vandana Singh Kushwaha, Sandeep Verma, Huma Khan, M.L.B. Bhatt, Nuzhat Husain, Mahendra Pal Singh Negi, Vivek Vidyadhar Bhosale & Ashim Ghatak. (2016) Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation. Heliyon 2:12, pages e00206.
Crossref
Crossref
Stefan Hartmann, Norbert Neckel, Axel Seher, Grit Mutzbauer, Roman C. Brands, Christian Linz, Alexander C. Kübler & Urs D. A. Müller-Richter. (2015) Erlotinib and gefitinib responsiveness in head and neck cancer cell lines—a comparing analysis with cetuximab. Clinical Oral Investigations 20:4, pages 759-769.
Crossref
Crossref